Interim Launch Management & Strategic Advisory
Senior MedTech Consultant | M.Sc. Mechanical Engineering | Specialist for Surgical Visualization & Capital Equipment
I answer the technical questions that pure marketers can't — and translate the answers into commercial strategy.
Key results — last global launch
What I offer
Built for MedTech companies launching complex capital equipment into competitive global markets.
01
A focused 2-week deep dive into your current GTM strategy. I identify the gaps in positioning, clinical messaging, and sales readiness that will slow down adoption, alignment, and early revenue.
Clear action plan across positioning, KOL strategy, sales execution, and launch sequencing — prioritized by impact.
Companies preparing for launch or already in-market and not seeing the traction they expected.
02
I embed as your interim Marketing or Product Lead for 6–12 months — from final R&D stages through pre-launch preparation to commercial rollout across regions and teams.x
Clinical Positioning & Messaging · Sales Enablement · GTM & Launch Execution · KOL & Evidence Strategy
Companies launching disruptive capital equipment in highly competitive markets and needing a senior expert to bridge the gap between late-stage R&D and global commercial excellence.
03
Ongoing MedTech consulting and strategic guidance for CEOs, CMOs, and Marketing Directors who need a senior medical device launch perspective without a full-time hire.
Monthly strategy sessions on positioning, market entry, or portfolio decisions · Ad-hoc input on critical decisions · Workshop facilitation
Senior leaders navigating a critical market entry, competitive repositioning, or launch decision — and needing senior outside perspective.
Proven in the field
A new entrant in a market dominated for 20+ years. The challenge was not the product — it was everything around it.
Case Study · Interim Launch Management
Challenge
Market Dominance
Duopoly controlled >90% of the advanced imaging segment, no trained field force, zero brand awareness for the new entrant.
Surgeon Skepticism
Deep resistance to switching from trusted analog optics to fully-digital 3D systems despite technical superiority.
Complex Sales Cycle
Capital equipment >350k €, 12–18 month multi-stakeholder decisions across clinical, procurement, and management.
Regulatory & Timing Risk
Delayed module approvals threatening pipeline momentum across EMEA, NA & APAC simultaneously.
No Clinical Proof Points
New entrant with no published data, no reference sites, and no peer-to-peer validation in a market where surgeon trust is built over years.
Strategic Interventions
Competitive Landscape & Battle Cards
Deep analysis of market leaders. Field-ready objection handlers enabling sales teams to convert from incumbent systems at capital equipment level.
Clinical Positioning & Messaging
Translated complex device capabilities into 4 clinical brand pillars, validated across global commercial and medical teams.
Field Force & Training Program
Developed and executed structured Sales Champion Training program for sales representatives and application specialists across 14+ markets, covering Digital Microscopy and Intraoperative Imaging systems.
GTM & Launch Package
Global go-to-market strategy including product videos, testimonials, brochures, and sales tools, deployed across EU, NA & APAC.
KOL & Evidence Strategy
Built international KOL network across key surgical specialties. Reference centers secured for clinical evidence, publications, wet labs and congress podium.
Background
"I translate complex MedTech technology into strategies that drive adoption, alignment, and revenue."
Most MedTech launches don't fail because of the product. They fail because engineering, clinical value, and commercial strategy are not aligned. My background bridges exactly that gap. With a foundation in mechanical engineering and over 10 years in international MedTech marketing, I understand how complex systems are built and how to bring them to market in ways that drive adoption against established players.
Available for selected mandates from H2 2026.
Florian Kayser
Interim Launch Management & Strategic Advisory
Selected Projects
3D Surgical Visualization Platform
Surgical Imaging · Global Launch
2nd Generation iOCT Imaging System
Surgical Imaging · Global Launch
Robotic Surgery Platform
Robotics · Public Seed BOM
Intraoperative Imaging · Neurosurgery
Diagnostics · BMBF funded
Intraoperative Imaging · ENT
Diagnostics · DACH Launch
Insights
Perspectives on what it really takes to bring complex medical devices to market.
Let's talk
Book a call directly or send a message. Either way — I'll respond within 48 hours with a clear perspective on whether I can help.
Location
Germany · Globally available
Availability
Taking on new mandates from July 2026 — conversations welcome now.
Book a call
Prefer to write first?
No problem — send a quick message and I'll get back to you within 48 hours.